Funding, News and Announcements

The LLS Translational Research Program was created in 1995 with the goal of accelerating clinical applications of laboratory findings relevant to improved diagnosis and management of leukemia, lymphoma, myeloma, and other hematopoietic malignancies. 

The program is looking for applications that propose novel approaches to the prevention, diagnosis, or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative and with a clear plan for the eventual clinical translation of the studies proposed and the results expected.

All applications are to be submitted online through the LLS Research Portal. 

Click here for more details.

Letter of Intent Deadline: October 16, 2024

For additional questions regarding LLS research grant programs, eligibility, and application processes, please contact researchprograms@lls.org.

The grants facilitator for your faculty can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.